(Q53242223)

12 May 2018

title

Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. (English)

1 reference

12 May 2018

cost-effectiveness analysis

main subject

child mortality

0 references

1 reference

2

Orin Levine

1 reference

12 May 2018

Maria Deloria Knoll

3

object named as

Maria D Knoll

1 reference

12 May 2018

author name string

Anushua Sinha

1

1 reference

12 May 2018

Farzana Muhib

4

1 reference

12 May 2018

Tracy A Lieu

5

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 February 2007

1 reference

12 May 2018

published in

The Lancet

1 reference

12 May 2018

volume

369

1 reference

12 May 2018

issue

9559

1 reference

12 May 2018

page(s)

389-396

1 reference

12 May 2018

Estimates of world-wide distribution of child deaths from acute respiratory infections

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Immunization, equity, and human rights.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Overcoming economic barriers to the optimal use of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Setting priorities for the Children's Vaccine Initiative: a cost-effectiveness approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Changes in the pattern of infant and childhood mortality in upper river division, The Gambia, from 1989 to 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

The world health report 2002 - reducing risks, promoting healthy life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Vaccine advance-purchase agreements for low-income countries: practical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

The potential indirect effect of conjugate pneumococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960195-0

7 January 2021

10.1016/S0140-6736(07)60195-0

Identifiers

DOI

1 reference

12 May 2018

release_ch5xp2a6urfl5nq2mfwld4tp3u

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ch5xp2a6urfl5nq2mfwld4tp3u

24 November 2022

mapped directly with Wikidata item

1 reference

12 May 2018